425: K-C, Kenvue Merger: Proxy Solicitation Update

Kimberly-Clark and Kenvue Inc. filed a Rule 425 communication regarding their proposed transaction, emphasizing the need for investor review of proxy materials.

Summary

• Kimberly-Clark Corporation (K-C) and Kenvue Inc. are engaged in a proposed transaction.
• This communication serves as solicitation material in respect of the proposed transaction.
• K-C and Kenvue intend to file a registration statement on Form S-4, which will include a joint proxy statement/prospectus, with the SEC.
• The definitive joint proxy statement/prospectus will be mailed to stockholders of both companies to seek their approval of respective transaction-related proposals.
• Investors and stockholders are urged to carefully read the registration statement and joint proxy statement/prospectus when they become available, as they will contain important information about the proposed transaction and any solicitation.
• Information about the directors and executive officers of K-C and Kenvue, considered participants in the proxy solicitation, is referenced in their respective Annual Reports on Form 10-K, proxy statements, and Current Reports on Form 8-K.
• The communication includes a cautionary statement regarding numerous forward-looking statements and associated risks that could cause actual results to differ materially.

Sentiment

Score: 5

Explanation: The filing is primarily a legal disclosure and cautionary statement, providing procedural information about a proposed transaction. While it mentions 'anticipated benefits,' it heavily emphasizes numerous risks and uncertainties, leading to a neutral sentiment.

Positives

• The communication represents a procedural step forward in the proposed transaction between Kimberly-Clark and Kenvue.
• It outlines the process for providing comprehensive information to stockholders through SEC filings, promoting transparency.

Negatives

• The communication highlights numerous risks and uncertainties that could cause actual results to differ materially from current expectations regarding the proposed transaction.
• There is a risk that the anticipated benefits and synergies of the proposed transaction may not be realized when expected or at all.
• The proposed transaction carries risks of unexpected costs or expenses, potential litigation, and disruption to ongoing business operations.

Risks

• Occurrence of any event, change, or circumstance that could give rise to the termination of the merger agreement, including circumstances requiring a party to pay a termination fee.
• Conditions to the completion of the proposed transaction (including stockholder and regulatory approvals) not being satisfied in a timely manner or at all.
• Possibility that competing offers or transaction proposals may be made.
• Risks arising from the integration of the K-C and Kenvue businesses.
• Uncertainty of rating agency actions.
• Anticipated benefits and synergies of the proposed transaction may not be realized when expected or at all.
• Proposed transaction may not be completed in a timely manner or at all.
• Unexpected costs or expenses resulting from the proposed transaction.
• Litigation related to the proposed transaction, including resulting expense or delay.
• Disruption to ongoing business operations and diversion of management's time as a result of the proposed transaction.
• Adverse effect on the ability of K-C and Kenvue to retain key personnel, customers, and suppliers.
• Credit ratings of the combined company declining following the proposed transaction.
• Announcement or consummation of the proposed transaction having a negative effect on the market price of the capital stock of K-C and Kenvue or on their operating results.
• Product liability litigation or government or regulatory action, including related to product liability claims.
• Product efficacy or safety concerns resulting in product recalls or regulatory action.
• Risks relating to inflation and other economic factors, such as interest rate and currency exchange rate fluctuations.
• Government trade or similar regulatory actions (including current and potential trade and tariff actions and other constraints on trade).
• Natural disasters, acts of war, terrorism, catastrophes, pandemics, epidemics, or other disease outbreaks.
• Prices and availability of K-Cs or Kenvues raw materials.
• Manufacturing difficulties or delays or supply chain disruptions.
• Disruptions in the capital and credit markets.
• Counterparty defaults (including customers, suppliers, and financial institutions).
• Impairment of goodwill and intangible assets and projections of operating results.
• Changes in customer preferences.
• Severe weather conditions, regional instabilities, and hostilities.
• Potential competitive pressures on selling prices for K-C and Kenvue products.
• Energy costs.
• General economic and political conditions globally and in the markets where K-C and Kenvue do business.
• Ability to maintain key customer relationships.
• Competition, including technological advances, new products, and intellectual property attained by competitors.
• Challenges inherent in new product research and development.
• Uncertainty of commercial success for new and existing products and digital capabilities.
• Challenges to intellectual property protections including counterfeiting.
• Ability of K-C and Kenvue to successfully execute business development strategy and other strategic plans.
• Changes to applicable laws and regulations and other requirements imposed by stakeholders.
• Changes in behavior and spending patterns of consumers.

Future Outlook

The filing contains forward-looking statements regarding the anticipated benefits of the proposed transaction, its impact on K-C's and Kenvue's business, and future financial and operating results and prospects. However, it explicitly states that there can be no assurance these future events will occur as anticipated or that results will be as estimated, due to numerous inherent risks and uncertainties beyond the companies' control.

Management Comments

• Kimberly-Clark Corporation published a social media post on November 3, 2025, in connection with the proposed transaction.
• John Carmichael, President, North America of Kimberly-Clark Corporation, published a social media post on November 3, 2025, in connection with the proposed transaction.

Industry Context

This filing is a procedural step in a significant corporate transaction between two major players in the consumer goods and healthcare sectors. Such mergers often reflect strategies for market consolidation, portfolio optimization, or achieving economies of scale in competitive industries, aiming to enhance market position and operational efficiency.

Legal Proceedings

• The filing identifies the risk of litigation related to the proposed transaction, including potential expenses or delays, as a forward-looking uncertainty.

Stakeholder Impact

• Shareholders of K-C and Kenvue will be required to vote on transaction-related proposals, and their approval is a condition for the transaction's completion.
• The proposed issuance of K-C's common stock as part of the transaction will directly impact the holdings of Kenvue shareholders.
• There is a risk that the announcement or consummation of the proposed transaction could negatively affect the market price of the capital stock for both K-C and Kenvue.
• The transaction poses a risk of adverse effects on the ability of K-C and Kenvue to retain key personnel, customers, and suppliers.
• Rating agencies may take actions regarding the credit ratings of the combined company following the proposed transaction.

Next Steps

• K-C and Kenvue intend to file a registration statement on Form S-4 with the SEC.
• The Form S-4 will include a joint proxy statement of K-C and Kenvue that also constitutes a prospectus of K-C.
• A definitive joint proxy statement/prospectus will be mailed to stockholders of K-C and Kenvue after the registration statement is declared effective by the SEC.
• Stockholders of K-C and Kenvue will be asked to approve their respective transaction-related proposals.

Key Dates

Keywords

Kimberly-Clark, Kenvue, Merger, Acquisition, SEC Filing, Form 425, Proxy Solicitation, Corporate Transaction, Consumer Goods, Healthcare, Personal Care